FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203750527> ?p ?o ?g. }

• W3203750527 abstract "Background: Shen-sui-tong-zhi formula (SSTZF) has been used to treat osteoporosis for decades and shows excellent clinical efficacy. This article aims to explore the optimal anti-osteoporotic ingredient and its precise mechanisms in mice models. Methods: In this study, we first screened the optimal anti-osteoporosis fraction of SSTZF extract in vivo , and then further explored the mechanism of its effects both in vivo and in vitro . Ten-week-old female C57BL/6J mice were administrated with each fraction of SSTZF. At 10 weeks after ovariectomy (OVX), femurs were collected for tissue analyses, including histology, micro-CT, biomechanical tests, and immunohistochemistry for ALP, FABP4, and β-catenin. Additionally, we also evaluated the mRNA expression level of ALP and FABP4 and the protein expression level of β-catenin after being treated with SSTZF extract in C 3 H 10 T1/2 cells. Moreover, we investigated the anti-osteoporosis effect of SSTZF extract on mice with β-catenin conditional knockout in growth plate chondrocytes ( β-catenin Gli1ER mice) through μCT, histology, and immunohistochemistry analyzes. Results: At 10 weeks after treatment, osteoporosis-like phenotype were significantly ameliorated in SSTZF n-butanol extract (SSTZF-NB) group mice, as indicated by increased trabecular bone area and ALP content, and decreased lipid droplet area and FABP4 content. No such improvements were observed after being treated with other extracts, demonstrating that SSTZF-NB is the optimal anti-osteoporosis fraction. Additionally, the elevated β-catenin was revealed in both OVX mice and C 3 H 10 T1/2 cells with SSTZF-NB administered. Furthermore, a significant osteoporosis-like phenotype was observed in β-catenin Gli1ER mice as expected. However, SSTZF-NB failed to rescue the deterioration in β-catenin Gli1ER mice, no significant re-upregulated ALP and downregulated FABP4 were observed after being treated with SSTZF-NB, demonstrating that SSTZF-NB prevents bone loss mainly via β-catenin signaling. Conclusion: SSTZF-NB enhances osteogenesis mainly via activation of β-catenin signaling in growth plate chondrocytes. SSTZF-NB is the optimal anti-osteoporosis fraction of SSTZF and it can be considered a salutary alternative therapeutic option for osteoporosis." @default.
• W3203750527 created "2021-10-11" @default.
• W3203750527 creator A5000647412 @default.
• W3203750527 creator A5013578643 @default.
• W3203750527 creator A5019689560 @default.
• W3203750527 creator A5023426417 @default.
• W3203750527 creator A5023872965 @default.
• W3203750527 creator A5027269816 @default.
• W3203750527 creator A5030779018 @default.
• W3203750527 creator A5031051951 @default.
• W3203750527 creator A5044707910 @default.
• W3203750527 creator A5050038706 @default.
• W3203750527 creator A5056937076 @default.
• W3203750527 creator A5065597174 @default.
• W3203750527 creator A5076479991 @default.
• W3203750527 creator A5081153209 @default.
• W3203750527 creator A5089611506 @default.
• W3203750527 date "2021-09-24" @default.
• W3203750527 modified "2023-09-23" @default.
• W3203750527 title "Fractions of Shen-Sui-Tong-Zhi Formula Enhance Osteogenesis Via Activation of β-Catenin Signaling in Growth Plate Chondrocytes" @default.
• W3203750527 cites W1502287122 @default.
• W3203750527 cites W1502693045 @default.
• W3203750527 cites W1970751450 @default.
• W3203750527 cites W2000825796 @default.
• W3203750527 cites W2010253303 @default.
• W3203750527 cites W2019137946 @default.
• W3203750527 cites W2028872252 @default.
• W3203750527 cites W2075452212 @default.
• W3203750527 cites W2136083716 @default.
• W3203750527 cites W2150343566 @default.
• W3203750527 cites W2269475172 @default.
• W3203750527 cites W2337159500 @default.
• W3203750527 cites W2369391196 @default.
• W3203750527 cites W2543931110 @default.
• W3203750527 cites W2556796709 @default.
• W3203750527 cites W2604504512 @default.
• W3203750527 cites W2724859405 @default.
• W3203750527 cites W2771225839 @default.
• W3203750527 cites W2792133195 @default.
• W3203750527 cites W2793880258 @default.
• W3203750527 cites W2810327208 @default.
• W3203750527 cites W2810551732 @default.
• W3203750527 cites W2887432875 @default.
• W3203750527 cites W2900297017 @default.
• W3203750527 cites W2900347078 @default.
• W3203750527 cites W2914240982 @default.
• W3203750527 cites W2918215206 @default.
• W3203750527 cites W2946110186 @default.
• W3203750527 cites W2980580897 @default.
• W3203750527 cites W2990075312 @default.
• W3203750527 cites W2996030525 @default.
• W3203750527 cites W3031956270 @default.
• W3203750527 cites W3033711033 @default.
• W3203750527 cites W3046697987 @default.
• W3203750527 cites W3080330051 @default.
• W3203750527 cites W3092280126 @default.
• W3203750527 cites W3095315521 @default.
• W3203750527 cites W3096754190 @default.
• W3203750527 cites W3128961813 @default.
• W3203750527 doi "https://doi.org/10.3389/fphar.2021.711004" @default.
• W3203750527 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8498212" @default.
• W3203750527 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34630086" @default.
• W3203750527 hasPublicationYear "2021" @default.
• W3203750527 type Work @default.
• W3203750527 sameAs 3203750527 @default.
• W3203750527 citedByCount "4" @default.
• W3203750527 countsByYear W32037505272021 @default.
• W3203750527 countsByYear W32037505272022 @default.
• W3203750527 countsByYear W32037505272023 @default.
• W3203750527 crossrefType "journal-article" @default.
• W3203750527 hasAuthorship W3203750527A5000647412 @default.
• W3203750527 hasAuthorship W3203750527A5013578643 @default.
• W3203750527 hasAuthorship W3203750527A5019689560 @default.
• W3203750527 hasAuthorship W3203750527A5023426417 @default.
• W3203750527 hasAuthorship W3203750527A5023872965 @default.
• W3203750527 hasAuthorship W3203750527A5027269816 @default.
• W3203750527 hasAuthorship W3203750527A5030779018 @default.
• W3203750527 hasAuthorship W3203750527A5031051951 @default.
• W3203750527 hasAuthorship W3203750527A5044707910 @default.
• W3203750527 hasAuthorship W3203750527A5050038706 @default.
• W3203750527 hasAuthorship W3203750527A5056937076 @default.
• W3203750527 hasAuthorship W3203750527A5065597174 @default.
• W3203750527 hasAuthorship W3203750527A5076479991 @default.
• W3203750527 hasAuthorship W3203750527A5081153209 @default.
• W3203750527 hasAuthorship W3203750527A5089611506 @default.
• W3203750527 hasBestOaLocation W32037505271 @default.
• W3203750527 hasConcept C104317684 @default.
• W3203750527 hasConcept C126322002 @default.
• W3203750527 hasConcept C127716648 @default.
• W3203750527 hasConcept C134018914 @default.
• W3203750527 hasConcept C150903083 @default.
• W3203750527 hasConcept C164659718 @default.
• W3203750527 hasConcept C185592680 @default.
• W3203750527 hasConcept C204232928 @default.
• W3203750527 hasConcept C207001950 @default.
• W3203750527 hasConcept C2776541429 @default.
• W3203750527 hasConcept C55493867 @default.
• W3203750527 hasConcept C57742111 @default.
• W3203750527 hasConcept C71924100 @default.
• W3203750527 hasConcept C86803240 @default.

• next